Friederike A G Meyer-Wentrup (Friederike Meyer-Wentrup)

Years Active: 2024-2024
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Emma Kroeze, Michelle M Kleisman, Lennart A Kester, Marijn A Scheijde-Vermeulen, Edwin Sonneveld, Jessica G C Buijs-Gladdines, Melanie M Hagleitner, Friederike A G Meyer-Wentrup, Margreet A Veening, Auke Beishuizen, Jules P P Meijerink, Jan L C Loeffen, Roland P Kuiper
NOTCH1 fusions in pediatric T-cell lymphoblastic lymphoma: A high-risk subgroup with CCL17 (TARC) levels as diagnostic biomarker. HemaSphere 8 (7) (2024)
Emma Kroeze, Michelle M Kleisman, Lennart A Kester, Marijn A Scheijde-Vermeulen, Edwin Sonneveld, Jessica G C Buijs-Gladdines, Melanie M Hagleitner, Friederike A G Meyer-Wentrup, Margreet A Veening, Auke Beishuizen, Jules P P Meijerink, Jan L C Loeffen, Roland P Kuiper
NOTCH1 fusions in pediatric T-cell lymphoblastic lymphoma: A high-risk subgroup with CCL17 (TARC) levels as diagnostic biomarker. HemaSphere 8 (7) (2024)
Jurrian K de Kanter, Alexander S Steemers, Daniel Montiel Gonzalez, Ravian L van Ineveld, Catharina Blijleven, Niels Groenen, Laurianne Trabut, Marijn A Scheijde-Vermeulen, Liset Westera, Auke Beishuizen, Anne C Rios, Frank C P Holstege, Arianne M Brandsma, Thanasis Margaritis, Ruben van Boxtel, Friederike A G Meyer-Wentrup
Single-cell RNA sequencing of pediatric Hodgkin lymphoma to study the inhibition of T cell subtypes. HemaSphere 8 (9) (2024)

Friederike A G Meyer-Wentrup.css-eqlu8i{font-size:small;padding-left:4px;} (Friederike Meyer-Wentrup)